Fundraising FoxCurapath
1 known investors
Find your way into Curapath
Sign up to see every warm intro you have to Curapath
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Curapath team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Curapath is a European Contract Development and Manufacturing Organization (CDMO) specializing in polymer- and lipid-based non-viral drug delivery systems for biotech and pharmaceutical companies. The company develops and manufactures lipid nanoparticles, polymer nanoparticles, and delivery components from early development through GMP-certified commercial manufacturing for oncology, cell and gene therapy, and vaccine applications.
Founders & leadership
P
PhilippeChief Executive Officer
V
VicentChief Technology Officer
Investors · 1
Columbus Venture Partnerslisted by Columbus Venture PartnersValenciavia Jose Mesa · inferred
How we know: Columbus Venture Partners's portfolio page · the VCSheet dataset · Not right? Tell us
In the news
Frequently asked questions
- What does Curapath do?
- Curapath is a European Contract Development and Manufacturing Organization (CDMO) specializing in polymer- and lipid-based non-viral drug delivery systems for biotech and pharmaceutical companies. The company develops and manufactures lipid nanoparticles, polymer nanoparticles, and delivery components from early development through GMP-certified commercial manufacturing for oncology, cell and gene therapy, and vaccine applications.
- Who are Curapath's investors?
- Curapath's investors include Columbus Venture Partners.